Apex Labs, INC

Apex Labs, INC was paid $1.58M by Medicaid between Jan 2018 and Jul 2024, across 47 billing codes. Its largest line is G0482, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed — 10% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Florida

Rank by total paid#33 of 225

Median peer was paid$74K

This provider vs. median21×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	168,632	$220K
2019	119,121	$352K
2020	54,285	$293K
2021	47,823	$527K
2022	21,497	$182K
2023	1,227	$5K
2024incomplete	338	$287.78

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	10%	13,914	9,703	$162K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	9.9%	26,657	15,657	$156K
80325		9.7%	8,924	6,225	$153K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	9.1%	10,146	7,737	$144K
80339		5.9%	6,876	4,347	$92K
80324		3.4%	5,203	2,497	$54K
80354		3.0%	12,230	7,220	$48K
80346		2.7%	11,435	7,910	$42K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	2.5%	6,367	3,537	$39K
80356		2.4%	13,340	8,349	$38K
80348		2.4%	12,226	8,413	$38K
80365		2.4%	19,449	8,430	$38K

35 more codes

80323		2.2%	5,362	$35K
80361		2.1%	12,173	$34K
80321		1.8%	963	$28K
80333		1.7%	7,804	$27K
80359		1.7%	13,349	$27K
80349		1.7%	11,043	$26K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	1.6%	2,178	$26K
80366		1.6%	8,947	$25K
80373		1.6%	10,809	$25K
80360		1.6%	10,127	$25K
80355		1.4%	8,769	$22K
80372		1.4%	10,137	$22K
80367		1.4%	10,529	$22K
80363		1.3%	4,194	$20K
80368		1.2%	10,666	$20K
80353		1.2%	13,339	$19K
80336		1.1%	6,223	$18K
80369		1.1%	2,681	$17K
80351		<1%	4,731	$16K
80371		<1%	19,295	$15K
83992		<1%	12,246	$15K
80358		<1%	11,542	$13K
80338		<1%	11,920	$12K
80362		<1%	4,951	$11K
80344		<1%	5,961	$11K
80370		<1%	6,986	$10K
82570		<1%	7,120	$8K
80364		<1%	4,637	$7K
80342		<1%	6,230	$6K
84311		<1%	13,377	$5K
80357		<1%	5,639	$5K
80343		<1%	386	$2K
80345		<1%	13	$737.24
80335		<1%	1,817	$709.35
80375		<1%	12	$62.55

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialNELSON, GREG (PRESIDENT)

Same official

Other billing entities under NELSON, GREG

Full network →

Provider	Location	Paid
Infiniti Labs, INC	Tampa, FL	$2.53M
Nelson-Nam a Medical Corporation	Van Nuys, CA	$86K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.